Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Selling, General & Administrative
|
Bristol-Myers Squibb Co
Selling, General & Administrative Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Selling, General & Administrative
-$7.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-5%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Selling, General & Administrative
-$21.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Pfizer Inc
NYSE:PFE
|
Selling, General & Administrative
-$14.5B
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Selling, General & Administrative
-$10.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Selling, General & Administrative
-$2.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Selling, General & Administrative
-$7.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
See Also
What is Bristol-Myers Squibb Co's Selling, General & Administrative?
Selling, General & Administrative
-7.9B
USD
-7.9B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Selling, General & Administrative amounts to -7.9B USD.
What is Bristol-Myers Squibb Co's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-5%
-5%
Over the last year, the Selling, General & Administrative growth was -2%. The average annual Selling, General & Administrative growth rates for Bristol-Myers Squibb Co have been -1% over the past three years , -12% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
